Methotrexate vs. ciclosporin in the treatment of severe atopic dermatitis in children: A critical appraisal

British Journal of Dermatology

Volumn 170, Issue 3, 2014, Pages 496-498

  Tsakok, T ^a   Flohr, C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EGYPT; EXTERNAL VALIDITY; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING OF ATOPIC DERMATITIS; SCORING SYSTEM; SECONDARY HEALTH CARE; UNSPECIFIED SIDE EFFECT; DERMATITIS, ATOPIC; FEMALE; MALE;

CYCLOSPORINE; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE;

EID: 84896072709     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12820     Document Type: Article

References (14)

1. Williams H, Stewart A, von Mutius E, et al,. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121: 947-54.e15.
2. McAleer MA, Flohr C, Irvine AD,. Management of difficult and severe eczema in childhood. BMJ 2012; 345: e4770.
3. Proudfoot LE, Powell A, Ayis S, et al,. The European treatment of severe atopic eczema in children taskforce (TREAT) survey. Br J Dermatol 2013; 169: 901-9.
4. Roberts H, Orchard D,. Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children. Australas J Dermatol 2010; 51: 128-30.
5. Hoare C, Li Wan Po A, Williams H,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 137: 1-191.
6. Schmitt J, Schäkel K, Schmitt N, Meurer M,. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007; 87: 100-11. (Pubitemid 46521989)
7. El-Khalawany MA, Hassan H, Shaaban D, et al,. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. Eur J Pediatr 2012; 172: 351-6.
8. Schulz KF, Altman DG, Moher D,. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152: 726-32.
9. Schram ME, Spuls PI, Leeflang MMG, et al,. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67: 99-106.
10. Schram ME, Roekevisch E, Leeflang MMG, et al,. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128: 353-9.
11. Williams HC,. Commentary: are methotrexate and azathioprine really equivalent for treating severe atopic eczema? Br J Dermatol 2012; 166: 705-7.
12. Patel AN, Langan SM, Batchelor JM,. A randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal. Br J Dermatol 2012; 166: 701-3.
13. De Angelis CD, Drazen JM, Frizelle FA, et al,. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 2005; 352: 2436-8. (Pubitemid 40958442)
14. Flohr C, Irvine AD,. Systemic therapies for severe atopic dermatitis in children and adults. J Allergy Clin Immunol 2013; 132: 774-6.e6.